To learn more about client services available from LabKey, please email info@labkey.com.

At the Fred Hutchinson Cancer Research Center (FHCRC),
interdisciplinary teams of world-renowned scientists and humanitarians
work together to prevent, diagnose and treat cancer, HIV/AIDS and other
diseases. The FHCRC uses LabKey Server
in a number of departments to manage proteomics, flow
cytometry and clinical study information.

The Statistical Center for HIV/AIDS Research & Prevention (SCHARP)
is part of the Public Health Sciences Division of the Fred Hutchinson
Cancer Research Center in Seattle, Washington. SCHARP provides
statistical collaboration to HIV/AIDS researchers around the world and
conducts a complementary program of statistical methodology and
mathematical modeling research. SCHARP also collects, manages, and
analyzes data from clinical trials and epidemiological studies
dedicated to the elimination of HIV/AIDS as a threat to human health.
LabKey Server stands at the the foundation of SCHARP's IT
infrastructure.

Based in Los Angeles, Cedars-Sinai Medical Center is the largest
nonprofit hospital in the western United States. It uses LabKey Server
as a shared proteomics database dedicated to mass spectrometry data.

Founded in 1861, the University of Washington is one of the oldest
state-supported institutions of higher education on the West Coast and
is one of the preeminent research universities in the world. Multiple
labs within the university use LabKey Server to provide
centralized, shared repositories for their flow cytometry and
proteomics
data.

The Center for HIV-AIDS Vaccine Immunology (CHAVI) is a consortium of
universities and academic medical centers established by the National
Institute of Allergy and Infectious Diseases (NIAID) under Barton
Haynes, MD, of Duke University. The Center's goal is to solve major
problems in HIV vaccine development and design. LabKey Server is
used to manage observational study and experimental data in support of
the CenterŐs objectives.

The Collaboration for AIDS Vaccine Discovery (CAVD) is an international
network of eleven Vaccine Discovery Consortia (VDCs) and five Central
Service Facilities (CSFs) funded by the Bill & Melinda Gates
Foundation. CAVD teams apply new technologies, concepts and
approaches to the
design of safe and effective preventive vaccines against HIV/AIDS. They
use LabKey Server as their central tool for collecting, managing,
analyzing,
tracking and sharing clinical trial datasets and experimental results.

The Canary Foundation supports researchers working towards a
standardized family of biomarker signatures for the effective and
accurate early detection of all forms of cancer. Supported by grants
awarded
through the foundation, LabKey Server is in use in the labs
of many key industry thought leaders, including: